GlassScriptPhysician profile
David Torres Barba
NPI 1447612676
$879.69
in general payments reported to CMS, 2019-2025
11 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $117 · 2022: $236 · 2023: $245 · 2024: $114 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $174.24 | 2024-2025 | Extended Holter, (Ck4) Mcot |
| Abbott Laboratories | $145.77 | 2022 | |
| Abiomed | $138.15 | 2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $127.37 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $116.67 | 2020 | |
| Amgen INC. | $46.31 | 2023-2024 | Repatha |
| Irhythm Technologies, INC. | $41.06 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Kestra Medical Technology Services, INC. | $30.75 | 2023 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $20.87 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $19.86 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.64 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Torres Barba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.